EDGAR Filing Documents for 0001062993-23-003492

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

SEC Accession No. 0001062993-23-003492

Filing Date

2023-02-14

Accepted

2023-02-14 17:27:36

Documents

Period of Report

2023-01-04

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	form4a.html	4/A
1	AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	form4a.xml	4/A	6556
2	POWER OF ATTORNEY	exhibit24.txt	EX-24	1778
	Complete submission text file	0001062993-23-003492.txt		9790

Mailing Address C/O KURA ONCOLOGY, INC. 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130

Business Address

Type: 4/A | Act: 34 | File No.: 001-41403 | Film No.: 23631968

Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801

Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 (617)871-2101

Comera Life Sciences Holdings, Inc. (Issuer) CIK: 0001907685 (see all company filings)

IRS No.: 874706968 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations